Search

everythinglearnresearchcommunity

for

Search:↓

Scientists found a new type of skin cell that could help with skin repair and these cells work better with a certain protein.

IL-27 may help prevent hair loss by creating immune-suppressing cells.

Amivantamab can cause severe skin eruptions and scarring, requiring drug discontinuation and early treatment.

New treatment effectively reverses hair thinning in most patients with mild side effects.

PBX1 helps hair stem cells grow and change by turning on certain cell signals and preventing cell death, which may be useful for hair regrowth treatments.

The combination of hair follicle stem cells and PRP shows promise for treating hair loss in Asian men and women.

The study found that certain mutations in the vitamin D receptor can cause rickets and potentially affect hair growth.

The complex oriental medicine extract was as effective as minoxidil for hair regrowth in mice without adverse effects.

Ruxolitinib helps regrow hair in alopecia areata by blocking inflammation, reducing stress, and controlling cell death.

Etanercept effectively treated a severe skin condition when other treatments failed.

A man regrew hair in 15 days using Pracchana and cupping therapy.

Combining Ficlatuzumab and Gefitinib can cause severe hair loss.

Injecting hyaluronidase into the artery is effective for treating skin death and hair loss caused by hyaluronic acid fillers.

Mice that can regenerate tissue have cells that pause in the cell cycle, which is important for healing, similar to axolotls.

The ATAN-Met hydrogel helps heal infected diabetic wounds by promoting tissue regeneration and fighting bacteria.

Adalimumab helped control a child's severe eye disease when other treatments failed.

The improved genome of the African spiny mouse helps study its tissue regeneration.

YAP and TAZ proteins are necessary for the development of two types of skin cancer.

Older men with scalp wounds had long-term healing problems after using imiquimod or diclofenac for skin cancer prevention.

Two transplant patients on cyclosporine unexpectedly developed hair loss.

Alternative treatments are needed when Tofacitinib alone fails for alopecia areata.

Scalp cooling can prevent chemotherapy-induced hair loss, and certain treatments can speed up hair regrowth, but more research is needed for better treatments.

Plasma as a graft holding solution improves hair transplant results by increasing graft survival and promoting hair growth.

Topical tofacitinib may effectively and safely regrow facial hair in some people with alopecia areata.

Upadacitinib successfully regrew hair in a child with alopecia universalis and specific genetic mutations.

CTHRC1 helps hair grow back, and plantar dermis mixture boosts it.

The conclusion is that a treatment called cp-asiAR can reduce hair loss and promote hair growth, making it a potential new therapy for androgenetic alopecia.

Ageratum houstonianum extract and agerarin may help hair growth.